(Q34397985)

1 August 2017

Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype (English)

1 reference

1 August 2017

1 reference

1 reference

Gross AS

1

1 reference

1 August 2017

Mikus G

2

1 reference

1 August 2017

Fischer C

3

1 reference

1 August 2017

Hertrampf R

4

1 reference

1 August 2017

Gundert-Remy U

5

1 reference

1 August 2017

Eichelbaum M

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 November 1989

1 reference

British Journal of Clinical Pharmacology

1 August 2017

1 reference

1 August 2017

28

1 reference

1 August 2017

5

1 reference

1 August 2017

555-566

1 reference

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

6 July 2018

Metabolism of flecainide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

The influence of urinary pH on flecainide excretion and its serum pharmacokinetics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

6 July 2018

Drug therapy. Flecainide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Oral flecainide pharmacokinetics in patients with impaired renal function

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Nonlinear least-squares regression programs for microcomputers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1380016

Is there a genetic factor in flecainide toxicity?

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1989.TB03542.X

The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1989.TB03542.X

Flecainide Half-Life Prolongation in 2 Patients with Congestive Heart Failure and Complex Ventricular

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1989.TB03542.X

High-performance liquid chromatographic method for the quantitation of a meta-O-dealkylated metabolite of flecainide acetate, a new antiarrhythmic

21 January 2018

1 reference

12 December 2020

Pharmacodynamics and side effects of flecainide acetate

1 reference

12 December 2020

Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function

1 reference

12 December 2020

[Elevated plasma flecainide concentrations in heart failure]

1 reference

12 December 2020

Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man

1 reference

12 December 2020

Pharmacokinetics of flecainide in patients with cirrhosis of the liver

1 reference

12 December 2020

Biotransformation and elimination of 14C-flecainide acetate in humans

1 reference

12 December 2020

10.1111/J.1365-2125.1989.TB03542.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference